Evidence that the tumor-suppressor protein BRCA2 does not regulate cytokinesis in human cells

被引:27
|
作者
Lekomtsev, Sergey [1 ,2 ]
Guizetti, Julien [3 ]
Pozniakovsky, Andrei [4 ]
Gerlich, Daniel W. [3 ]
Petronczki, Mark [1 ,2 ]
机构
[1] Canc Res UK London Res Inst, Clare Hall Labs, Cell Div, S Mimms EN6 3LD, Herts, England
[2] Canc Res UK London Res Inst, Clare Hall Labs, Aneuploidy Lab, S Mimms EN6 3LD, Herts, England
[3] Swiss Fed Inst Technol Zurich ETHZ, Inst Biochem, CH-8093 Zurich, Switzerland
[4] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany
关键词
BRCA2; Cytokinesis; Chromosomal instability; Cell division; Mitosis; CANCER SUSCEPTIBILITY; INHIBITOR; MUTATIONS; RAD51;
D O I
10.1242/jcs.068015
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Germline mutations in the tumor-suppressor gene BRCA2 predispose to breast and ovarian cancer. BRCA2 plays a well-established role in maintaining genome stability by regulating homologous recombination. BRCA2 has more recently been implicated in cytokinesis, the final step of cell division, but the molecular basis for this remains unknown. We have used time-lapse microscopy, recently developed cytokinesis assays and BAC recombineering (bacterial artificial chromosome recombinogenic engineering) to investigate the function and localization of BRCA2 during cell division. Our analysis suggests that BRCA2 does not regulate cytokinesis in human cells. Thus, cytokinesis defects are unlikely to contribute to chromosomal instability and tumorigenesis in BRCA2-related cancers.
引用
收藏
页码:1395 / 1400
页数:6
相关论文
共 50 条
  • [31] Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells
    S Hibino
    Y Saito
    T Muramatsu
    A Otani
    Y Kasai
    M Kimura
    H Saito
    Oncogenesis, 2014, 3 : e104 - e104
  • [32] Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells
    Hibino, S.
    Saito, Y.
    Muramatsu, T.
    Otani, A.
    Kasai, Y.
    Kimura, M.
    Saito, H.
    ONCOGENESIS, 2014, 3 : e104 - e104
  • [33] Effects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cell lines
    Vissac-Sabatier, C
    Bignon, YJ
    Bernard-Gallon, DJ
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2003, 45 (02): : 247 - 255
  • [34] Safeguarding genome stability: RASSF1A tumor suppressor regulates BRCA2 at stalled forks
    Pefani, Dafni Eleftheria
    O'Neill, Eric
    CELL CYCLE, 2015, 14 (11) : 1624 - 1630
  • [35] Molecular genetic analysis of the BRCA2 tumor suppressor gene region in cutaneous squamous cell carcinomas
    Gray, Sarah E.
    Kay, Elaine
    Leader, Mary
    Mabruk, Mohamed
    JOURNAL OF CUTANEOUS PATHOLOGY, 2008, 35 (01) : 1 - 9
  • [36] Immunohistochemical analysis of BRCA2 expression in normal human buccal cells
    Byrne, TJ
    Cohn, GM
    Lane, MA
    Adams, LA
    Hoffman, DE
    Reece, MT
    ONCOLOGY REPORTS, 2000, 7 (05) : 955 - 958
  • [37] Identification of MAGI1 as a tumor-suppressor protein induced by cyclooxygenase-2 inhibitors in colorectal cancer cells
    J Zaric
    J-M Joseph
    S Tercier
    T Sengstag
    L Ponsonnet
    M Delorenzi
    C Rüegg
    Oncogene, 2012, 31 : 48 - 59
  • [38] Identification of MAGI1 as a tumor-suppressor protein induced by cyclooxygenase-2 inhibitors in colorectal cancer cells
    Zaric, J.
    Joseph, J-M
    Tercier, S.
    Sengstag, T.
    Ponsonnet, L.
    Delorenzi, M.
    Rueegg, C.
    ONCOGENE, 2012, 31 (01) : 48 - 59
  • [39] Characterization of C4-2 as a tumor-suppressor gene in human brain tumors
    Sehgal, A
    Keener, C
    Boynton, AL
    Young, RF
    Vermeulen, SS
    Yonemura, KS
    Kohler, EP
    Aldape, HC
    Simrell, CR
    Murphy, GP
    JOURNAL OF SURGICAL ONCOLOGY, 1997, 64 (02) : 102 - 108
  • [40] NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells
    Keller, Maureen
    Dubois, Fatemeh
    Teulier, Sylvain
    Martin, Alexandre P. J.
    Levallet, Jerome
    Maille, Elodie
    Brosseau, Solenn
    Elie, Nicolas
    Hergovich, Alexander
    Bergot, Emmanuel
    Camonis, Jacques
    Zalcman, Gerard
    Levallet, Guenaelle
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38